Alector (ALEC) Form 144 Discloses RSU Vesting and Planned Sale
Rhea-AI Filing Summary
Alector, Inc. (ALEC) filing of Form 144 reports an intended sale of 15,426 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $36,251.10. The filing shows approximately 101,212,329 shares outstanding and lists an approximate sale date of 09/02/2025.
The securities were acquired on 08/29/2025 by vesting of restricted stock units (30378 units originally noted) with payment dated 08/29/2025. The filer also disclosed a prior sale: 11,158 shares sold on 06/02/2025 for gross proceeds of $14,933.87. The notice contains the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 disclosure for an insider sale; size is small relative to outstanding shares and follows RSU vesting.
The Form 144 shows an intended disposition of 15,426 shares with a stated aggregate market value of $36,251.10 and an approximate sale date of 09/02/2025. The securities were acquired by RSU vesting on 08/29/2025 (30,378 units referenced), indicating this is a post-vesting sale of newly acquired shares rather than a purchase or loan-funded transaction. A prior sale of 11,158 shares on 06/02/2025 for $14,933.87 is also disclosed. From a market-impact perspective, the disclosed amounts are modest relative to the 101,212,329 shares outstanding reported in the filing.
TL;DR: Filing appears compliant with Rule 144 disclosure requirements; includes broker and acquisition details.
The notice identifies the broker (Morgan Stanley Smith Barney LLC) and provides the acquisition method as vesting of restricted stock units on 08/29/2025, which aligns with customary disclosure practices for insider-derived shares. The filing contains the required representation regarding material nonpublic information. There are no statements in the filing indicating any unusual arrangements or exceptions to standard Rule 144 requirements.